Aim: We determined the long-term role of increased RDW (red blood cell distribution width) detected during cardiac decompensation.Methods: We followed 3697 patients [mean age 71.4 years (±SD 10.1), 59.1% males] hospitalized for acute heart failure (HF) and assessed the five-year all-cause mortality risk associated with tertiles of RDW.Results: Patients with RDW in the top tertile showed roughly twofold higher 5-year mortality risk than those in the bottom tertile. The association remained significant not only after adjustments for potential covariates but even if we excluded patients who deceased during the first year of follow-up [HRR 1.76 (95% CIs:1.42-2.18), p < 0.0001].Conclusion: The high degree of anisocytosis represents an independent predictor of poor prognosis in HF patients, even long-term after an acute manifestation.

[Box: see text].

Biomedical Center Medical Faculty of Charles University Pilsen Czech Republic

Centre for Cardiovascular Prevention 1st Medical Faculty of Charles University and Thomayer University Hospital Prague Czech Republic

Department of Informatics University Hospital Pilsen Czech Republic

ND Department of Internal Medicine Medical Faculty of Charles University and University Hospital Pilsen Czech Republic

See more in PubMed

Savarese G, Becher PM, Lund LH, et al. . Global burden of heart failure: a comprehensive and updated review of epidemiology. Cardiovasc Res. 2023;118(17):3272–3287. doi:10.1093/cvr/cvac013 PubMed DOI

England JM, Down MC. Red-cell-volume distribution curves and the measurement of anisocytosis. Lancet. 1974;1(7860):701–703. doi:10.1016/s0140-6736(74)92904-3 PubMed DOI

Sadaka F, O'Brien J, Prakash S. Red cell distribution width and outcome in patients with septic shock. J Intensive Care Med. 2013;28(5):307–313. doi:10.1177/0885066612452838 PubMed DOI

Lorente L, Martín MM, Abreu-González P, et al. . Red blood cell distribution width during the first week is associated with severity and mortality in septic patients. PloS One. 2014;9(8):e105436. doi:10.1371/journal.pone.0105436 PubMed DOI PMC

Kim CH, Park JT, Kim EJ, et al. . An increase in red blood cell distribution width from baseline predicts mortality in patients with severe sepsis or septic shock. Crit Care. 2013;17(6):R282. doi:10.1186/cc13145 PubMed DOI PMC

Wang F, Pan W, Pan S, et al. . Red cell distribution width as a novel predictor of mortality in ICU patients. Ann Med. 2011;43(1):40–46. doi:10.3109/07853890.2010.521766 PubMed DOI

Lee JH, Chung HJ, Kim K, et al. . Red cell distribution width as a prognostic marker in patients with community-acquired pneumonia. Am J Emerg Med. 2013;31(1):72–79. doi:10.1016/j.ajem.2012.06.004 PubMed DOI

Purtle SW, Moromizato T, McKane CK, et al. . The association of red cell distribution width at hospital discharge and out-of-hospital mortality following critical illness. Crit Care Med. 2014;42(4):918–929. doi:10.1097/ccm.0000000000000118 PubMed DOI

Zhang Z, Xu X, Ni H, Deng H. Red cell distribution width is associated with hospital mortality in unselected critically ill patients. J Thorac Dis. 2013;5(6):730–736. doi:10.3978/j.issn.2072-1439.2013.11.14 PubMed DOI PMC

Said AS, Spinella PC, Hartman ME, et al. . RBC distribution width: biomarker for red cell dysfunction and critical illness outcome? Pediatr Crit Care Med. 2017;18(2):134–142. doi:10.1097/pcc.0000000000001017 PubMed DOI PMC

van Kimmenade RR, Mohammed AA, Uthamalingam S, et al. . Red blood cell distribution width and 1-year mortality in acute heart failure. Eur J Heart Fail. 2010;12(2):129–136. doi:10.1093/eurjhf/hfp179 PubMed DOI

Yao L, Tan Y, Chen F. Correlation between galectin-3, RDW, Hepc, HS and ferritin and prognosis of patients with acute onset of chronic heart failure. BMC Cardiovasc Disord. 2022;22(1):471. doi:10.1186/s12872-022-02847-8 PubMed DOI PMC

Melchio R, Rinaldi G, Testa E, et al. . Red cell distribution width predicts mid-term prognosis in patients hospitalized with acute heart failure: the RDW in Acute Heart Failure (RE-AHF) study. Intern Emerg Med. 2019;14(2):239–247. doi:10.1007/s11739-018-1958-z PubMed DOI

Makhoul BF, Khourieh A, Kaplan M, et al. . Relation between changes in red cell distribution width and clinical outcomes in acute decompensated heart failure. Int. J. Cardiol. 2013;167(4):1412–1416. doi:10.1016/j.ijcard.2012.04.065 PubMed DOI

Mayer O, Bruthans J, Bilkova S, et al. . The prognosis and therapeutic management of patients hospitalized for heart failure in 2010-2020. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2022;166(3):312–321. doi:10.5507/bp.2022.020 PubMed DOI

Krynský T, Mayer O Jr, Bruthans J, et al. . Dosing of basic pharmacotherapy and its effect on the prognosis of patients hospitalized for heart failure. Vnitr Lek. 2023;69(2):109–118. doi:10.36290/vnl.2023.018 PubMed DOI

Levey AS, Stevens LA, Schmid CH, et al. . A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604–612. doi:10.7326/0003-4819-150-9-200905050-00006 PubMed DOI PMC

Duchnowski P, Hryniewiecki T, Kuśmierczyk M, Szymański P. The usefulness of selected biomarkers in aortic regurgitation. Cardiol J. 2019;26(5):477–482. doi:10.5603/CJ.a2018.0108 PubMed DOI PMC

Förhécz Z, Gombos T, Borgulya G, et al. . Red cell distribution width in heart failure: prediction of clinical events and relationship with markers of ineffective erythropoiesis, inflammation, renal function, and nutritional state. Am Heart J. 2009;158(4):659–666. doi:10.1016/j.ahj.2009.07.024 PubMed DOI

Felker GM, Allen LA, Pocock SJ, et al. . Red cell distribution width as a novel prognostic marker in heart failure: data from the CHARM Program and the Duke Databank. J Am Coll Cardiol. 2007;50(1):40–407. doi:10.1016/j.jacc.2007.02.067 PubMed DOI

Holmström A, Sigurjonsdottir R, Hammarsten O, et al. . Red blood cell distribution width and its relation to cardiac function and biomarkers in a prospective hospital cohort referred for echocardiography. Eur J Intern Med. 2012;23(7):604–609. doi:10.1016/j.ejim.2012.05.005 PubMed DOI

Kawasoe S, Kubozono T, Ojima S, et al. . Combined assessment of the red cell distribution width and B-type natriuretic peptide: a more useful prognostic marker of cardiovascular mortality in heart failure patients. Intern Med. 2018;57(12):1681–1688. doi:10.2169/internalmedicine.9846-17 PubMed DOI PMC

Piagnerelli M, Boudjeltia KZ, Vanhaeverbeek M, Vincent JL. Red blood cell rheology in sepsis. Intens Care Med. 2003;29(7):1052–1061. doi:10.1007/s00134-003-1783-2 PubMed DOI

Rogers SC, Said A, Corcuera D, et al. . Hypoxia limits antioxidant capacity in red blood cells by altering glycolytic pathway dominance. FASEB J. 2009;23(9):3159–3170. doi:10.1096/fj.09-130666 PubMed DOI PMC

Goyette RE, Key NS, Ely EW. Hematologic changes in sepsis and their therapeutic implications. Semin Respir Crit Care Med. 2004;25(6):645–659. doi:10.1055/s-2004-860979 PubMed DOI

Ibrahim Eel D, McLellan SA, Walsh TS. Red blood cell 2,3-diphosphoglycerate concentration and in vivo P50 during early critical illness. Crit Care Med. 2005;33(10):2247–2252. doi:10.1097/01.ccm.0000181675.39370.3d PubMed DOI

Condon MR, Kim JE, Deitch EA, et al. . Appearance of an erythrocyte population with decreased deformability and hemoglobin content following sepsis. Am J Physiol Heart Circ Physiol. 2003;284(6):H2177–2184. doi:10.1152/ajpheart.01069.2002 PubMed DOI

Doctor A, Platt R, Sheram ML, et al. . Hemoglobin conformation couples erythrocyte S-nitrosothiol content to O2 gradients. Proc Natl Acad Sci USA. 2005;102(16):5709–5714. doi:10.1073/pnas.0407490102 PubMed DOI PMC

Scharte M, Fink MP. Red blood cell physiology in critical illness. Crit Care Med. 2003;31(Suppl. 12):S651–S657. doi:10.1097/01.ccm.0000098036.90796.ed PubMed DOI

Gallagher AM, Setakis E, Plumb JM, et al. . Risks of stroke and mortality associated with suboptimal anticoagulation in atrial fibrillation patients. Thromb Haemost. 2011;106(5):968–977. doi:10.1160/th11-05-0353 PubMed DOI

Gallagher PG. Disorders of red cell volume regulation. Curr Opin Hematol. 2013;20(3):201–207. doi:10.1097/MOH.0b013e32835f6870 PubMed DOI

Said A, Rogers S, Doctor A. Red cell physiology and signaling relevant to the critical care setting. Curr Opin Pediatr. 2015;27(3):267–276. doi:10.1097/mop.0000000000000225 PubMed DOI PMC

Köseoğlu FD, Özlek B. Hemoglobin to red cell distribution width ratio in patients with heart failure with preserved ejection fraction. Int J Cardiol. 2024;397:131556. doi:10.1016/j.ijcard.2023.131556 PubMed DOI

Groenveld HF, Januzzi JL, Damman K, et al. . Anemia and mortality in heart failure patients a systematic review and meta-analysis. J Am Coll Cardiol. 2008;52(10):818–827. doi:10.1016/j.jacc.2008.04.061 PubMed DOI

Swedberg K, Young JB, Anand IS, et al. . Treatment of anemia with darbepoetin alfa in systolic heart failure. N Engl J Med. 2013;368(13):1210–1219. doi:10.1056/NEJMoa1214865 PubMed DOI

Scicchitano P, Iacoviello M, Massari A, et al. . Anaemia and congestion in heart failure: correlations and prognostic role. Biomedicines. 2023;11(3):972. doi:10.3390/biomedicines11030972 PubMed DOI PMC

Maggioni AP, Anker SD, Dahlström U, et al. . Are hospitalized or ambulatory patients with heart failure treated in accordance with European Society of Cardiology guidelines? Evidence from 12,440 patients of the ESC Heart Failure Long-Term Registry. Eur J Heart Fail. 2013;15(10):1173–1184. doi:10.1093/eurjhf/hft134 PubMed DOI

Van Craenenbroeck EM, Conraads VM, Greenlaw N, et al. . The effect of intravenous ferric carboxymaltose on red cell distribution width: a subanalysis of the FAIR-HF study. Eur J Heart Fail. 2013;15(7):756–762. doi:10.1093/eurjhf/hft068 PubMed DOI

Khan MS, Usman MS, von Haehling S, et al. . Ferric carboxymaltose for the treatment of iron-deficient heart failure patients: a systematic review and meta-analysis. ESC Heart Fail. 2020;7(6):3392–3400. doi:10.1002/ehf2.13146 PubMed DOI PMC

Yamani N, Ahmed A, Gosain P, et al. . Effect of iron supplementation in patients with heart failure and iron deficiency: a systematic review and meta-analysis. Int J Cardiol Heart Vasc. 2021;36:100871. doi:10.1016/j.ijcha.2021.100871 PubMed DOI PMC

Orct J, Bílková S, Krynský T, Jirák J. Prescription of basic pharmacotherapy and its dosage in outpatients care after discharge in patients hospitalized for cardiac decompensation. CorVasa. 2024. [in press]. doi:10.33678/cor.2024.036 DOI